Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias
- 1 January 1986
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 111 (1) , 42-48
- https://doi.org/10.1016/0002-8703(86)90551-x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metaboliteClinical Pharmacology & Therapeutics, 1983
- Pharmacology of ASL-8052, a Novel β-Adrenergic Receptor Antagonist with an Ultrashort Duration of ActionJournal of Cardiovascular Pharmacology, 1983
- A Double-Blind Trial of Metoprolol in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Ultra-short-acting .beta.-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl functionJournal of Medicinal Chemistry, 1982
- β-Adrenoceptor Antagonists: New Drugs and New IndicationsNew England Journal of Medicine, 1981